Member Info for BenNa

Massive indication on Jamaica and UOG has the potential to 7 billion barrels of #oil

,

https://www.argusmedia.com/en/news-and-insights/latest-market-news/2652873-jamaica-discusses-proposals-for-kingston-refinery

Jamaica attracting major oil investors.... Huge news

Buys started

These two for next week Mac and N4P

@n4pharma

Look like cryptic message on @n4pharma twitter X account

Unbelievable potential said by Former AVCT CEO and founder

Mac

N4p

1p bought a while back.....

Next week is dead cert approval??

Deepseek Ai..... Game changer for Biotech sector.....

N4p will be using this...... It's only matter of time!!

AVCT former CEO and Founder said N4p is massively undervalued!!

N4p £2.5m mcap 😳

A new test for #IBD patients predicts bowel cancer risk with over 90% accuracy by detecting #DNA changes in pre-cancerous cells. It helps high-risk patients get early intervention while sparing others from unnecessary procedures. Learn more: tinyurl.com/2wazysze

#N4P

Https://x.com/n4pharma/status/1885251685041201317?t=z4xyxiE_b98Qsj5SZajk6Q&s=19

The market cap I find absolutely extraordinary.

It won’t be here too long if they start getting positive data from in vivo N4101 studies. #N4P

One clear fact I would ask anyone to research; MULTIPLE RNA able to be easily loaded, protected and delivered within the GUT.

£2.5m.. unbelievable

Source : X poster

5m shares getting quote at 1.2p

10m shares quoted for 1.75p

After that no more stocks!!!!

Tells me all I need to know

Former AVCT CEO and founder took AVCT to over £300m mcap

If N4p can replica this sort of Mcap from current Share price then expect few multi Millionaires!!

I'm backing the Team at N4p to get this project going......

Cancer therapy and delivery to Precise cells without side effect..... Hmm

Worth billions.!!!

Just think one day a bio tech would get a similar rise on a deal.

Unbelievable rise, well done all

Say this new Director gets a massive deal worth £394m, then N4p Sp would be worth £1

Think about the risk v Reward

Hardly any risk but reward is enormous

That's over 120 bagger from current levels

Holders to be millionaires if this sort of deal goes through

Tiny mcap £25m for a cancer RNAi therapeutic. Similar one sold for £800m

Schulm

I agree this is far too under the radar company and under valued.

£15m to £20m seems good for what it has achieved.

Just think a bigger player would be looking to buy this out at £20m

Https://x.com/Darrenukdaytra1/status/1884921394393157665?t=7BSFCxVZb0MUKqmMt_QQPA&s=19

This is started to get chartist interest.......

Wow!

$825m

Arrowhead Pharma and Sarepta Therapeutics' $825M RNAi licensing deal highlights the value of platform-based innovation in drug discovery. N4 Pharma is leveraging its platform with key assets N4101 and ECP 105, both available for licensing

That's like 300 bagger.....should a deal of this magnitude were to go ahead.

Won't mind 100 bagger deal..

EX Avct CEO and founder is the new man to take @n4pharma to the promised land

Gap at 2.4p

Huge upside from here onwards

Bullish on all technical indicators

Suggest news coming.........